AIMD Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (18 Apr 2024 @ 16:00):

Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications...

Stats
Today's Volume	9 786.00
Average Volume	1.39M
Market Cap	6.13M
EPS	$0 ( 2024-03-29 )
Next earnings date	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.310
ATR14	$0.0110 (1.07%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-18	Lee Hsin-liang Christopher	Buy	0
2024-02-16	Lee Ting-chuan	Sell	14 400	RSU
2024-02-16	Lee Ting-chuan	Buy	14 400	CommonStock
2024-02-16	Sung Meng Lin	Buy	1 050	Common Stock
2024-02-16	Sung Meng Lin	Sell	1 050	RSU

INSIDER POWER
24.04
Last 95 transactions
Buy: 22 138 064 \| Sell: 12 377 869

Ainos, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ainos, Inc. Financials

Annual	2023
Revenue:	$122 112
Gross Profit:	$-5.11M (-4 181.56 %)
EPS:	$-3.36

Q4	2023
Revenue:	$19 904.00
Gross Profit:	$-1.31M (-6 582.15 %)
EPS:	$-1.270

Q3	2023
Revenue:	$24 489.00
Gross Profit:	$-63 384.00 (-258.83 %)
EPS:	$-0.730

Q2	2023
Revenue:	$28 555.00
Gross Profit:	$-27 262.00 (-95.47 %)
EPS:	$-0.580

Financial Reports:

No articles found.

Ainos, Inc.

Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.